Access to hematopoietic stem cell transplant for patients with sickle cell anemia

被引：5

作者：

Meier, Emily Riehm ^{[1
]}

Johnson, Theodore ^{[2
]}

Pinkney, Kerice ^{[3
]}

Velez, Maria C. ^{[4
]}

Kamani, Naynesh ^{[5
]}

Odame, Isaac ^{[6
]}

机构：

[1] Indiana Hemophilia & Thrombosis Ctr, 8326 Naab Rd, Indianapolis, IN 46220 USA

[2] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA

[3] Joe DiMaggio Childrens Hosp, Div Pediat Hematol Oncol, Hollywood, FL USA

[4] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Childrens Hosp, New Orleans, LA USA

[5] AABB, Bethesda, MD USA

[6] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada

来源：

PEDIATRIC BLOOD & CANCER | 2018年 / 65卷 / 09期

关键词：

diversity; healthcare disparities; hematopoietic stem cell transplant; hydroxyurea; sickle cell anemia; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; HEALTH-CARE; ACADEMIC MEDICINE; CONTROLLED-TRIAL; UNITED-STATES; DISEASE; RISK; US;

D O I：

10.1002/pbc.27105

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

引用

页数：5

共 35 条

[1]

American College of Physicians, 2010, RAC ETHN DISP HLTH C

[2]

[Anonymous], 2001, REP BRIEF CROSS QUAL

[3]

[Anonymous], 2016, 2015 NAT HEALTHC QUA

[4] Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis [J].

Arnold, Staci D. ;

Jin, Zhezhen ;

Sands, Stephen ;

Bhatia, Monica ;

Kung, Andrew L. ;

Satwani, Prakash .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (07) :1258-1265

[5]

Association of American Medical Colleges, 2012, DIV MED ED FACTS FIG

[6] The Impact of Hydroxyurea on Career and Employment of Patients With Sickle Cell Anemia [J].

Ballas, Samir K. ;

Bauserman, Robert L. ;

McCarthy, William F. ;

Waclawiw, Myron A. .

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2010, 102 (11) :993-999

[7] The cost of health care for patients with sickle cell disease [J].

Ballas, Samir K. .

AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (06) :320-322

[8]

Bertrand M, 2003, MIT DEP EC WORKING P

[9] 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study [J].

Bhatia, Smita ;

Landier, Wendy ;

Hageman, Lindsey ;

Kim, Heeyoung ;

Chen, Yanjun ;

Crews, Kristine R. ;

Evans, William E. ;

Bostrom, Bruce ;

Casillas, Jacqueline ;

Dickens, David S. ;

Maloney, Kelly W. ;

Neglia, Joseph P. ;

Ravindranath, Yaddanapudi ;

Ritchey, A. Kim ;

Wong, F. Lennie ;

Relling, Mary V. .

BLOOD, 2014, 124 (15) :2345-2353

[10] Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group [J].

Bhatia, Smita ;

Landier, Wendy ;

Shangguan, Muyun ;

Hageman, Lindsey ;

Schaible, Alexandra N. ;

Carter, Andrea R. ;

Hanby, Cara L. ;

Leisenring, Wendy ;

Yasui, Yutaka ;

Kornegay, Nancy M. ;

Mascarenhas, Leo ;

Ritchey, A. Kim ;

Casillas, Jacqueline N. ;

Dickens, David S. ;

Meza, Jane ;

Carroll, William L. ;

Relling, Mary V. ;

Wong, F. Lennie .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2094-2101

← 1 2 3 4 →